共 50 条
Identifying and Managing Patients with Elevated Breast Cancer Risk Presenting for Screening Mammography
被引:3
作者:
Patel, Neema J.
[1
,3
]
Mussallem, Dawn M.
[2
]
Maimone, Santo
[1
]
机构:
[1] Mayo Clin, Dept Radiol, Jacksonville, FL USA
[2] Mayo Clin, Dept Hematol Oncol, Jacksonville, FL USA
[3] Dept Radiol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA
关键词:
High-risk;
Tyrer-Cuzick;
screening mammogram;
breast cancer;
risk reducing medication;
MRI;
SOCIETY;
MODELS;
WOMEN;
D O I:
10.1067/j.cpradiol.2022.04.006
中图分类号:
R8 [特种医学];
R445 [影像诊断学];
学科分类号:
1002 ;
100207 ;
1009 ;
摘要:
Background: Identifying the prevalence and management of patients at high-risk for breast cancer can improve resource utilization and provide individualized screening strategies. Objective: The purpose of this study was to identify the prevalence of high-risk patients in our institution who presented for screening mammography and to understand how they utilized downstream resources offered to them. Materials and Methods: This single institution retrospective study utilized the Tyrer-Cuzick risk assessment model to provide lifetime risk of breast cancer of patients presenting for screening mammography over a one-year period. Their subsequent management and resource utilization were collated. Results: High-risk patients comprised 7.7% (701/9061) of our screening population. Of those high-risk women offered a Breast Center (BC) consultation, 75.2% (276/367) participated in the consultation, with 51.1% (141/276) of those patients completing MRI for supplemental screening. Risk reducing medication was adopted by 7.6% (6/79) of those offered. Of patients offered a genetics consultation, 66.3% (53/80) participated in the consultation, and 50.0% (40/80) completed genetic testing. Conclusions: Identifying and understanding high-risk patient cohorts, whether locally or in a population-based context, is important for individualized patient care and practice efficiency. (c) 2022 Published by Elsevier Inc.
引用
收藏
页码:838 / 841
页数:4
相关论文
共 50 条